Medication info
Spitin Tablet 20 mg (Atorvastatin Calcium Trihydrate)

Spitin Tablet 20 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›20.7mg / 1 tablet
Manufacturer / importer
Daewoong Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200807684 · Notified 2008.07.10 · Insurance code 641602880

Summary

Main use
Improvement of hyperlipidemia (including pediatric familial hyperlipidemia) and prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg once daily or 40 mg (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate for each patient according to the recommended treatment goals. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Daewoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including pediatric familial hyperlipidemia) and prevention of cardiovascular disease

  • Coronary artery heart disease
  • myocardial infarction
  • stroke
  • angioplasty
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • type 2 diabetes
  • congestive heart failure
  • angina
  • hyperlipidemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. It is particularly effective in reducing the risk of myocardial infarction and stroke, as well as lowering the risk of angioplasty and angina. It plays a role in treating hyperlipidemia by lowering major cholesterol levels and increasing good HDL cholesterol. Additionally, it is used for treating dyslipidemia in pediatric patients aged 10 to 17 years with a familial predisposition or many risk factors for cardiovascular diseases. This medication is effective in protecting heart health and improving vascular-related issues.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg once daily or 40 mg (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate for each patient according to the recommended treatment goals. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication may cause unusual muscle reactions, so if muscle pain or weakness worsens, you should immediately stop taking it and consult your doctor. In particular, if there is a significant increase in muscle enzyme levels or suspicion of serious myopathy, the medication should be discontinued. It should not be used in patients with liver function problems or liver disease, and regular liver function tests are required. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication, and fertile women should use appropriate contraception while on this medication. Children or pediatric patients under 10 years old should not take this medication. Caution is needed for patients with a history of alcoholism or liver disease, elderly patients, and patients with decreased kidney function, and they should carefully monitor for side effects. It may interact with other medications, especially when combined with certain antibiotics, antifungals, antivirals, immunosuppressants, and some lipid-lowering agents. This medication contains lactose, so patients with lactose intolerance should not take it. If symptoms of liver and muscle dysfunction appear during treatment, you should promptly inform your doctor and regular blood tests and liver function tests will be necessary. There is no specific antidote for overdose, and treatment should be based on symptoms while monitoring liver function and muscle enzyme levels. Store out of reach of children, keep in the original container, and avoid transferring to other containers.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 154 more
  • anorexia
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • dysgeusia
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • rupture-related complications
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive urine leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • elevated cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory abnormalities
  • vertigo
  • photosensitive reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • motor coordination ataxia
  • torticollis
  • facial paralysis
  • hyperkinesis
  • depression
  • tension
  • arthritis
  • bursitis
  • synovitis
  • myasthenia gravis
  • tendon contraction
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequency of urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic changes
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discoloration of urine
  • hypothermia
  • hyperlipidemia
  • facial flushing
  • increased non-protein nitrogen
  • hyperuricemia
  • gingival hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. A storage temperature between 1 degree and 30 degrees Celsius is recommended.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.